$28B pharma deal, Bill Marriott interview: The National Observer Dec. 13, 2022

Amgen Inc. has reached a $28 billion deal to acquire Horizon Therapeutics PLC. Amgen has slimmed down its own operations but remained an opportunistic acquirer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.